Sonoma Pharmaceuticals Inc. (SNOA)
NASDAQ · Healthcare
Sonoma Pharmaceuticals Inc. Long Term Debt 2011–2025
Sonoma Pharmaceuticals Inc. annual long term debt history from 2011 to 2021. Long term debt refers to financial obligations that are due more than one year in the future.
- Sonoma Pharmaceuticals Inc. long term debt as of March 31, 2021: 1.3M, a 292.22% increase year-over-year.
- Sonoma Pharmaceuticals Inc. long term debt for 2021 were 1.3M, a 292.22% increase from 2019.
- Sonoma Pharmaceuticals Inc. long term debt for 2019 were 334,000, a 27.48% increase from 2018.
- Sonoma Pharmaceuticals Inc. long term debt for 2018 were 262,000, a 52.33% increase from 2017.
- Sonoma Pharmaceuticals Inc. long term debt for 2017 were 172,000.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Sonoma Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2021 | $1 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2014 | $0 |
| 2013 | $3 |
| 2012 | $2 |
| 2011 | $2 |
Sonoma Pharmaceuticals Inc. Long Term Debt — FAQ
Sonoma Pharmaceuticals Inc. (SNOA) long term debt over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SNOA's long term debt history?
The chart and table above show Sonoma Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.